IRB Barcelona logo

News

Highlighting IRB Barcelona's impact on society

News

Antony Nevin, Artist in Residence 2019, at IRB Barcelona
Outreach
A new creative in our midst
Modesto Orozco during the award ceremony
Innovation
The spin-off Nostrum Biodiscovery wins the 2019 Senén Vilaró Prize
To ensure adequate levels of proteins in the cell, a strict quality control system is responsible for tagging the proteins with ubiquitin for degradation. Francisco Martínez, IRB Barcelona.
Scientific - Nature Cancer
Researchers at IRB Barcelona study how altered protein degradation contributes to the development of tumours
Manuel Serrano, ICREA researcher at IRB Barcelona, during his talk at the Barcelona Biomed Conference.
Institutional
International scientists point to immunotherapy as a new approach for treating diseases related to ageing
ENABLE symposium 2019
Institutional
The 3rd ENABLE symposium focuses on new challenges in science
Researchers at IRB Barcelona have identified these genetic footprints produced by some cancer treatments and have for the first time been able to calculate the genetic toxicity of some of these treatments. Claudia Arnedo, IRB Barcelona.
Scientific - Nature Genetics
Genetic alterations caused by cancer therapies identified
José Picón (Fundación Tatiana Pérez de Guzmán el Bueno-FTPGB), Ángel Carracedo, César Nombela (Fúndación Carmen y Severo Ochoa-FCSO), Salvador Aznar (IRB Barcelona), Rosa Menéndez (CSIC), César de Haro (FCSO) y Alvaro Matud (FTPGB)
Institutional
Salvador Aznar Benitah receives the “Premio Fundación Carmen y Severo Ochoa 2019”
Fran Supek, head of the Genome Data Science laboratory at IRB Barcelona
Institutional
Fran Supek becomes an EMBO Young Investigator
Roger Gomis, head of the Growth Control and Metastasis Laboratory, IRB Barcelona.
Institutional
Researcher Roger Gomis receives a grant from the Fundación Fero to study metastatic breast cancer

Media Mentions

Blog

Do you want to be informed?

Visit our blog.

IRB Blog